|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C12N 5/12 | (2006.01) | ||
| A61K 47/48 | (2006.01) | ||
| A61K 51/10 | (2006.01) |
| (11) | Number of the document | 2311877 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011773.8 |
| Date of filing the European patent application | 2006-11-24 | |
| (97) | Date of publication of the European application | 2011-04-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-08-26 |
| (46) | Date of publication of the claims translation | 2016-01-11 |
| (30) | Number | Date | Country code |
| 05025657 | 2005-11-24 | EP |
| (72) |
Sahin, Ugur, DE
Türeci, Özlem, DE
Usener, Dirk, DE
Fritz, Stefan, DE
Uherek, Christoph, DE
Brandenburg, Gunda, DE
Geppert, Harald-Gerhard, DE
Schröder, Anja Kristina, DE
Thiel, Philippe, DE
|
| (73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8411, JP |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui |
| Monoclonal antibodies against claudin-18 for treatment of cancer |
| Payment date | Validity (years) | Amount | |
| 2024-10-31 | 19 | 347.00 EUR |
| 2025-11-24 |